Targeted drug delivery system Market - Current Impact to Make Big Changes by 2035
The prevalence of chronic diseases has increased significantly over the past few decades. Presently, around 129 million people in the US have at least one life threating chronic condition, such as heart disease, cancer, diabetes, obesity or hypertension.
The global targeted drug delivery device market size is projected to grow from $427 Million in 2026 to $2,153 Million by 2035, representing a CAGR of 19.7% during the forecast period.
Additionally, about 90% of the annual USD 4.1 trillion health care expenditure is attributed to managing and treating chronic diseases and mental health conditions. Thus, rising incidence of chronic diseases, coupled with aging population has led to a surge in the demand for novel drugs, including complex small molecules and biologics, across multiple therapeutic areas.
https://www.rootsanalysis.com/....reports/targeted-dru
